Editorial Perspective: challenges of research focusing on child and adolescent mental health during the COVID-19 era: what studies are needed?
Editorial Perspective: challenges of research focusing on child and adolescent mental health during the COVID-19 era: what studies are needed?
This editorial perspective focuses on the challenges of research on child and adolescent mental health during the COVID-19 pandemic. Common limitations of published/ongoing studies are (i) being conducted in one or few countries, (ii) the survey being available in one or few languages, (iii) targeting selected samples (e.g., clinical populations and health workers) rather than the general population, (iv) only recruiting/reporting on non-representative samples, (v) focusing often on a restricted set of mental health outcomes, missing the broader picture of mental and physical health, quality of life and functioning, (vi) failing to use a longitudinal design and (vii) collecting only parental ratings or self-rated questionnaires from children and adolescents, but not both. We discuss how the Collaborative Outcomes Study on Health and Functioning during Infection Times (COH-FIT) was designed to address some of these challenges, also highlighting its limitations.
122-125
Solmi, Marco
41042fed-4194-4e86-930f-14f8f2f36458
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Correll, Christoph
c064b210-2758-47f0-ab9d-f5a42b211a92
January 2022
Solmi, Marco
41042fed-4194-4e86-930f-14f8f2f36458
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Correll, Christoph
c064b210-2758-47f0-ab9d-f5a42b211a92
Solmi, Marco, Cortese, Samuele and Correll, Christoph
(2022)
Editorial Perspective: challenges of research focusing on child and adolescent mental health during the COVID-19 era: what studies are needed?
Journal of Child Psychology & Psychiatry, 63 (1), .
(doi:10.1111/jcpp.13478).
Abstract
This editorial perspective focuses on the challenges of research on child and adolescent mental health during the COVID-19 pandemic. Common limitations of published/ongoing studies are (i) being conducted in one or few countries, (ii) the survey being available in one or few languages, (iii) targeting selected samples (e.g., clinical populations and health workers) rather than the general population, (iv) only recruiting/reporting on non-representative samples, (v) focusing often on a restricted set of mental health outcomes, missing the broader picture of mental and physical health, quality of life and functioning, (vi) failing to use a longitudinal design and (vii) collecting only parental ratings or self-rated questionnaires from children and adolescents, but not both. We discuss how the Collaborative Outcomes Study on Health and Functioning during Infection Times (COH-FIT) was designed to address some of these challenges, also highlighting its limitations.
Text
Editorial_COH-FIT_jcpp
- Author's Original
More information
Accepted/In Press date: 4 June 2021
Published date: January 2022
Additional Information:
Funding Information:
M.S. has received honoraria from Lundbeck and worked in advisory board of Angelini. S.C. declares honoraria and reimbursement for travel and accommodation expenses for lectures from the following non-profit associations: Association for Child and Adolescent Central Health (ACAMH), Canadian ADHD Alliance Resource (CADDRA), British Association of Pharmacology (BAP) and from Healthcare Convention for educational activity on ADHD. C.U.C. has been a consultant and/or advisor to or has received honoraria from Acadia, Alkermes, Allergan, Angelini, Axsome, Gedeon Richter, Gerson Lehrman Group, Indivior, IntraCellular Therapies, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Medscape, Merck, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Servier, Sumitomo Dainippon, Sunovion, Supernus, Takeda and Teva. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck, Rovi, Supernus and Teva. He has received grant support from Bendheim Foundation, Berlin Institute of Health, Janssen, National Institute of Mental Health, USA, Patient Centered Outcomes Research Institute and Takeda. He is also a stock option holder of LB Pharma.
Funding Information:
In terms of funding, acknowledging that collecting data early and quickly during the pandemic was crucial, COH‐FIT has relied on the voluntary work of a large number of unfunded researchers, inviting members of the consortium to prospectively apply for local, national and international funding, with part of this funding used to pay polling companies for representative sampling and/or central costs (e.g., website‐related and data storage/management costs). This strategy has been successful so far, with patchwork funding from internal funds, local and national grants.
Publisher Copyright:
© 2021 Association for Child and Adolescent Mental Health.
Identifiers
Local EPrints ID: 451128
URI: http://eprints.soton.ac.uk/id/eprint/451128
ISSN: 1469-7610
PURE UUID: 93e29bbb-4478-4ba5-bfb4-04631421477d
Catalogue record
Date deposited: 14 Sep 2021 10:37
Last modified: 17 Mar 2024 03:37
Export record
Altmetrics
Contributors
Author:
Marco Solmi
Author:
Christoph Correll
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
